We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00227175
First Posted: September 27, 2005
Last Update Posted: April 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Weill Medical College of Cornell University
  Purpose
To explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population.

Condition Intervention
Hypertension Behavioral: Semi-structured, open ended interview

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study

Further study details as provided by Weill Medical College of Cornell University:

Estimated Enrollment: 60
Study Start Date: April 2003
Estimated Study Completion Date: September 2003
Detailed Description:
  1. The first goal is to explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population. Through a series of open-ended questions we will explore and build a better understanding of how hypertensive African American patients view their illness and the difficulties they have in taking their antihypertensive medications as prescribed.
  2. The second goal of the qualitative phase is to use the responses obtained to inform how we should operationalize and tailor the positive affect induction and self-affirmation intervention methods in hypertensive African American patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients must be self-identified as African-Americans.
  2. All patients must be aged 18 years and older.
  3. All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure > 140 mm hg or a diastolic blood pressure > 90 mm hg or if participants are taking any prescribed antihypertensive medication.
  4. Patients must be able to provide informed consent in English.

Exclusion Criteria:

  1. Patients who refuse to participate
  2. Patients who are unable to provide informed consent.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00227175


Locations
United States, New York
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Carla Boutin-Foster, MD, MS Weill Medical College of Cornell University
Principal Investigator: Gbenga Ogedegbe, MD, MS Columbia University
Study Director: Mary E Charlson, MD Weill Medical College of Cornell University
  More Information

Publications:
Factors That Influence Medication Adherence Among African-Americans With Hypertension. Moore, JA, Boutin-Foster, C, Charlson, ME. Weill Medical College of Cornell University, New York, NY. Presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Mary E. Charlson, MD, Weill Cornell Medical College
ClinicalTrials.gov Identifier: NCT00227175     History of Changes
Other Study ID Numbers: N01-HC-25196 (0103-659)
First Submitted: September 23, 2005
First Posted: September 27, 2005
Last Update Posted: April 3, 2008
Last Verified: March 2008

Keywords provided by Weill Medical College of Cornell University:
African American
Hypertension
Medication adherence
Risk reduction

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases